📰 Statement Regarding News
Page 50 - Statement Regarding News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Statement Regarding. Real-time updates on events, politics, business and more.
November 30, 2022
29.11.2022 - NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, BC / ACCESSWIRE / November 29, 2022 / BioNxt Solutions Inc. (BioNxt or the Company) (CSE:BNXT)(OTCQB:XPHYF)(FSE:4XT), an international ...
November 30, 2022
Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF), a clean technology company developing transformative power conversion technologies and control system
November 29, 2022
In-house lawyers need to know what to do upon receiving an investigative subpoena in an antitrust or white-collar matter.
November 29, 2022
On November 10, the Federal Trade Commission (FTC) issued a “Policy Statement Regarding the Scope of Unfair Methods of Competition Under Section 5 of the Federal Trade Commission Act”...
November 29, 2022
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, BC / ACCESSWIRE / November 29, 2022 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:XPHYF)(FSE:4XT)
November 28, 2022
VANCOUVER, BC / ACCESSWIRE / November 28, 2022 / SILVER X MINING CORP. (TSXV:AGX)(OTCQB:AGXPF)(FRA:WPZ) ("Silver X" or the "Company") is pleased to report its interim financial results for the three and
November 25, 2022
Labrador Uranium Inc. (âLURâ, âLabrador Uraniumâ, or âthe Companyâ -
November 24, 2022
TORONTO, Nov. 24, 2022 (GLOBE NEWSWIRE) -- Labrador Uranium Inc. (“LUR”, “Labrador Uranium”, or “the Company”) (CSE: LUR, OTCQB: LURAF, FRA: EI1) is...
November 23, 2022
EQS-News: Defence Therapeutics Inc. / Key word(s): Study Defence Therapeutics Inc.: DEFENCE’S SUCCESSFULL STUDY ON THE ACCUVAC-PT007 VACCINE TARGETING CERVICAL CANCER 23.11.2022 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. ______________________________...
November 23, 2022
Vancouver, British Columbia--(Newsfile Corp. - November 23, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company